Polycystic ovary syndrome
Therapeutic area
Endocrinology
Rare disease
No
- Definition
- A disorder that manifests as multiple cysts on the ovaries. It results in hormonal imbalances and leads to irregular and abnormal menstrual periods, excess growth of hair, acne eruptions and obesity.
- Genetic basis
- Yes
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Polycystic ovary syndrome
- Therapeutic area
- Endocrinology
- polycystic ovary syndrome
- Obese Subjects With Polycystic Ovary Syndrome (PCOS)
- PCOS
- PCOS (Polycystic Ovary Syndrome)
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- PCOS (Polycystic Ovary Syndrome) of Left Ovary
- PCOS (Polycystic Ovary Syndrome) of Right Ovary
- PCOS, Insulin Resistance
- PCOS(Insulin Resistant)
- polycystic ovarian disease
- Polycystic Ovarian Syndrome (PCOS)
- polycystic ovaries
- Polycystic Ovaries Syndrome
- Polycystic Ovary Syndrome (PCOS)
- Polycystic Ovary Syndrome (PCOS) With Concurrent Nonalcoholic Fatty Liver Disease (NAFLD)
- Polycystic Ovary Syndrome (PCOS) Women
- Polycystic Ovary Syndrome (PCOS), Anovulatory Infertility
- Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
- Polycystic Ovary Syndrome,
- Polycystic Ovary Syndrome, PCOS
- Stein-Leventhal syndrome
- PCOS1
- polycystic ovary syndrome 1
- All therapeutic areas
- Endocrinology
Sources for recorded values
- Severity
- Mild
- Genetic
- Hereditary
- Syndromic
Sources for recorded values
- MONDO ID
- MONDO:0008487
- Parent condition
- MONDO:0002254
Related records
Broader conditions (8)
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Disease of genetic or genomic mechanism
- Endocrine system disorder
- Hereditary disease
- Human disease
- Syndromic disease
Trials (962)
- "KETOGENIC MEDITERRANEAN VERSUS HYPOCALORIC BALANCED DIET ON POLYCYSTIC OVARIAN ADOLESCENTS"
- 14 Weeks Exercise Training on Lean Women With and Without PCOS
- 30000 IU Per Week Vitamin D Treatment in PCOS Patients
- 71A/G HSD17B5 SNP and Effects of Oral Contraceptive Pill in PCOS Women
- A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
- A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
- A Comparison of a PULSE Diet and the TLC Diet on Reproductive, Metabolic Parameters in Women with PCOS
- A Comparison of Letrozole and Clomifene Citrate
- A Cooking and Eating Study
- A Metabolomic Study of Polycystic Ovary Syndrome With Insulin Resistance and Its Relationship With TCM Syndrome Types
- A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype
- A New Algorithm to Predict Ovarian Age
- A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS
- A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome
- A Reduced Carbohydrate Diet Intervention for Polycystic Ovary Syndrome (PCOS)
- A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
- A Study of AZD4901 in Females With Polycystic Ovary Syndrome
- A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
- A Study to Evaluate the Effect of Elix Cycle Balance and Daily Harmony on Polycystic Ovary Syndrome
- A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Approved drugs (2)
- Clomiphene citrate
- Histrelin
Drugs in development (100)
- Acetylcarnitine Phase 2
- Acetylcysteine Phase 2
- Anakinra Phase 2
- Arginine Phase 3
- Artenimol Phase 2
- Astaxanthin Phase 1
- Atorvastatin Phase 2
- Atorvastatin calcium Phase 2
- Bicalutamide Phase 1
- Bromocriptine Phase 3
- Cabergoline Phase 2
- Calcium Phase 3
- Canagliflozin Phase 1
- Carnitine Phase 2
- Cetrorelix Phase 3
- Cetrorelix acetate Phase 3
- Chiglitazar Phase 2
- Cholecalciferol Phase 3
- Choriogonadotropin alfa Phase 2
- Chromium Phase 3
Other linked drugs (31)
- Acarbose
- Aklomide
- Albumin human
- Amlodipine
- Amlodipine maleate
- Berberine
- Berberine sulfate
- Bifidobacterium SPP.
- Chlormadinone acetate
- Clomiphene
- Degarelix
- Dexamethasone
- Diazoxide
- Estrogen
- Fenofibrate
- Follitropin alfa
- Hydrocortisone
- Leuprolide
- Levothyroxine
- Magnesium